Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
Qian Wu, Yan Shi, Li Chen, Xiaoyi Xiao, Guanghai Dai Department of Multimodality Therapy Oncology, Chinese PLA General Hospital, Beijing, People’s Republic of China Purpose: To review the clinical data and treatment efficacy of bevacizumab in Chinese patients with metastatic colorectal can...
Main Authors: | Wu Q, Shi Y, Chen L, Xiao XY, Dai GH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-04-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/effect-and-safety-of-bevacizumab-containing-chemotherapy-treatment-in--a12914 |
Similar Items
-
Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
by: Geva R, et al.
Published: (2013-01-01) -
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
by: S Whyte, et al.
Published: (2010-10-01) -
Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
by: Xu R, et al.
Published: (2018-12-01) -
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy
by: Zhiming Wang, et al.
Published: (2016-09-01) -
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
by: Zoratto F, et al.
Published: (2012-09-01)